ROUNDTABLE Ditching the Virus: Is This The Future of Gene Therapy Delivery?
Wednesday, May 31, 2023 10:45 AM - 11:45 AM
Room 242B
Bioprocessing & Biomanufacturing
Roundtable
What are the technology and regulatory challenges for adoption of non-viral gene therapy?
Moderator
Greg Crescenzi, MBA, Chief Commercial Officer, KYTOPEN, USA
Panelists
Shirley Bartido, PhD, MBA, Director, Global Regulatory Affairs Cell Therapy Oncology, Takeda Pharmaceutical Company Limited, USA
Madhusudan V. Pshwa, PhD, Chief Technology Officer, Cell Therapy, Cell Therapy Tessera Therapeutics, USA
Justin Travis McCue, PhD, CTO, Avectas, USA
Kevin Holden, PhD, MBA, Head of Science, Synthego, USA
Learning Objectives:
Moderator
Greg Crescenzi, MBA, Chief Commercial Officer, KYTOPEN, USA
Panelists
Shirley Bartido, PhD, MBA, Director, Global Regulatory Affairs Cell Therapy Oncology, Takeda Pharmaceutical Company Limited, USA
Madhusudan V. Pshwa, PhD, Chief Technology Officer, Cell Therapy, Cell Therapy Tessera Therapeutics, USA
Justin Travis McCue, PhD, CTO, Avectas, USA
Kevin Holden, PhD, MBA, Head of Science, Synthego, USA
Learning Objectives:
- What is working and what is not?
- Where are we seeing advances and challenges in technology? And also with regards to regulations?
- What lessons have been learned by those who have moved first?
- What can we expected to happen next? What still need to be done?
- Where and why are the new technologies still falling short?
- What are the next steps (short and long term) needed to make change and move the industry along faster, better and safer?
Shirley Bartido PhD, MBA
Director, Global Regulatory Affairs Cell Therapy Oncology
Takeda Pharmaceutical Company Limited
Panelist
Director, Global Regulatory Affairs Cell Therapy Oncology
Takeda Pharmaceutical Company Limited
Panelist
Madhusudan V. Peshwa PhD
Chief Technology Officer, Cell Therapy
Cell Therapy Tessera Therapeutics
Panelist
Chief Technology Officer, Cell Therapy
Cell Therapy Tessera Therapeutics
Panelist